DM
BITI

Deerfield Management’s BIOTIE THERAPIES CORP SPONSORED ADR BITI Stock Holding History

Deerfield Management’s Portfolio BITI Stock Details BITI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-219,558
Closed -$2.87M – 143
2015
Q3 		$2.87M Hold
219,558
– – 0.11% 105
2015
Q2 		$4.38M Buy
+219,558
New +$4.58M 0.15% 96

Other funds holding BITI

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Deerfield Management's BITI Position: Q4 2015 in Review

Deerfield Management sold out of BIOTIE THERAPIES CORP SPONSORED ADR (BITI) in Q4 2015, closing a stake of 219,558 shares — an estimated $2.87M sold.

Deerfield Management first reported a position in BITI in Q2 2015 and held it in 2 quarters. The position peaked at $4.38M in Q2 2015. 15 funds tracked by Wall St. Rank hold BITI as of Q4 2015.

  • Deerfield Management reported no remaining BIOTIE THERAPIES CORP SPONSORED ADR position as of Q4 2015 after selling out during the quarter.
  • Deerfield Management sold 219,558 BIOTIE THERAPIES CORP SPONSORED ADR shares in Q4 2015, an estimated $2.87M.
  • Deerfield Management first reported a position in BIOTIE THERAPIES CORP SPONSORED ADR in Q2 2015 and held it in 2 quarters.
  • Deerfield Management's BIOTIE THERAPIES CORP SPONSORED ADR position peaked at $4.38M in Q2 2015.
  • 15 funds tracked by Wall St. Rank held BIOTIE THERAPIES CORP SPONSORED ADR as of Q4 2015.

Based on Deerfield Management's 13F filing for Q4 2015, filed 16 Feb 2016.